Abbott Laboratories vs. Contineum Therapeutics, Inc. Class A Common Stock
ABT
Abbott Laboratories
$99.60 +1.13%
VS CTNMContineum Therapeutics, Inc. Class A Common Stock
$8.56 -35.99%
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | CTNM | |
|---|---|---|
| Market Cap | $172.35 billion | $503.37 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | CTNM | |
|---|---|---|
| Dividend Yield | 2.53% | — |
ABT and CTNM split the dividend factors evenly.
Risk & Sentiment
| ABT | CTNM | |
|---|---|---|
| Short Interest | 0.57% | 1.59% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, CTNM overview, CTNM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.